Animal & Veterinary
NSAID Labels
Currently Approved Labels for Companion Animal NSAIDs
This page contains a partial collection of the labeling that has been submitted to the FDA Center for Veterinary Medicine (FDA CVM) by veterinary product sponsors. The labeling includes product information for veterinary professionals (Package Inserts - PI) and for animal owners (Client Information Sheets – CIS). Information in the labeling includes the indications for use, dosage form, route of administration, and the recommended dosage.
Please be advised several hyper-links leave the FDA/CVM.gov domain and connect to external sponsor Websites. These links provide access to labeling that could not be posted on a .gov domain due to technical difficulties. However, while the information was accurate at the time of posting and was consistent with the intended purpose of the FDA CVM Web site, FDA CVM cannot attest to the accuracy of information provided by these external links or any other externally linked site. In addition, providing links to a non-FDA Web site does not constitute an endorsement by FDA or CVM or any of its employees of the sponsors of the site or the information or products presented on the site. Also, be aware that the privacy protection provided on the FDA.gov domain (see Privacy Statement and Other Information About FDA’s Website) may not be available at the external link.
If the product labeling you require is not electronically available, please submit a written Freedom of Information Act (FOIA) request. Information on how to submit an FOIA request can be found in "A Handbook for Requesting Information and Records from FDA". CVM can not accept FOI requests via E-mail.
- CVM Update - FDA Seeks Comment on the Electronic Distribution of Prescribing Information for Prescription Animal Drug Products, October 22, 2007
- Federal Register Notice - Docket No. 2007N-0114, OC 2007236. Electronic Distribution of Prescribing Information for Prescription Drug Products; Reopening of Comment Period. Pages 59536-59537 [FR Doc. E7-20759] October 22, 2007. Comments due December 6, 2007
In addition, you can access the Websites of drug sponsors for labeling information.
DERAMAXX
Equioxx
EtoGesic
Metacam
- Metacam 0.5 mg/mL Oral Suspension, NADA 141-213, Client Information Sheet (PDF - 257KB)
August 2006 - Metacam 0.5 mg/mL Oral Suspention, NADA 141-213, Package Insert (PDF - 1001KB)
August 2006 - Metacam 1.5 mg/mL Oral Suspension, NADA 141-213, Client Information Sheet (PDF - 3560KB)
January 2005 - Metacam 1.5 mg/mL Oral Suspension, NADA 141-213, Package Insert (PDF - 1949KB)
January 2005 - Metacam 0.5 mg/mL Solution for Injection, NADA 141-219, Package Insert (PDF - 47KB)
October 2004
Novox
Previcox
Rimadyl
- RIMADYL® Caplets, NADA 141-053, Client Information Sheet (PDF - 489KB)
January 2004 - RIMADYL® Caplets, NADA 141-053, Package Insert (PDF - 53KB)
January 2004 - RIMADYL® Chewable Tablets, NADA 141-111, Client Information Sheet (PDF - 142KB)
January 2004 - RIMADYL® Chewable Tablets, NADA 141-111, Package Insert (PDF - 752KB)
January 2004 - RIMADYL® Sterile Injectable Solution, NADA 141-199, Package Insert (PDF - 80KB)
September 2005
